Skip to main content
Figure 5 | Journal of Clinical Bioinformatics

Figure 5

From: Diagnostic markers based on a computational model of lipoprotein metabolism

Figure 5

VLDL performance response to treatment. Average VLDL performance response (on identity line) to Atorvastatin, Simvastatin and Fenofibrate treatment in mixed hyperlipidemic patients [24, 25]. P-values for VLDL performance were calculated by the Wilcoxon rank-sum test. Bilz Atorvastatin: n = 5, p = 0.0925; Bilz Fenofibrate: n = 5, p = 0.0079; Forster Atorvastatin: n = 9, p = 0.0482; Forster Simvastatin: n = 11, p = 0.0006. All treatments caused VLDL performance to move towards healthier values.

Back to article page